Momenta Sues Viatris Over Copaxone Generic – Five Years After Launch

Viatris’ Partner Natco: ‘This Is A Meritless Suit’

 
• By Dean Rudge

One Copaxone (glatiramer acetate) ANDA sponsor is suing another for alleged patent infringement, with Momenta filing a lawsuit against Viatris and its partners in a US district court.

Argument (Brain light/Alamy Stock Photo)
Momenta has accused Mylan and partners of infringement • Source: Shutterstock (Brain light / Alamy Stock Photo/Alamy Stock Photo)

More from Legal & IP

More from Generics Bulletin